Skip to the page

Data / Form D filings / AB Science S.A.

AB Science S.A.: Form D filings

AB Science S.A., a biotechnology company in Paris, France, filed 4 Form D notices with the SEC between 2017 and 2026. The latest, on July 17, 2026, reports $2 million sold of a $2 million offering to 2 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
3, AVENUE GEORGE V, Paris, France, 75008
Phone
33 (0)1 47 20 00 14
Industry
Biotechnology
Entity type
Corporation
Incorporated in
France
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1703850

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jul 17, 2026New notice$2,016,160$2,016,1602Jul 3, 2026sec.gov
May 18, 2026New notice$2,989,368$2,989,3682May 4, 2026sec.gov
Apr 14, 2017New notice$20,284,415$20,284,41515Apr 4, 2017sec.gov
Apr 14, 2017New notice$16,299,000$16,299,00011Mar 29, 2017sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Stephane LedermannExecutive Officer, Director
Laurent GuyExecutive Officer
Christian FassotteExecutive Officer
Alexis BernardExecutive Officer
Alain MoussyDirector
Patrick MoussyDirector
Cecile de GuillebonDirector
Guillemette LatschaDirector
Catherine Johnston-RoussillonDirector

Every Form D from the week of Jul 13, 2026 · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what AB Science S.A. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.